ASX - By Stock
|
IMM |
Re:
Ann: Phase II study for eftilagimod alpha in COVID-19 advances
|
|
weaponhead
|
127 |
65K |
1 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
127
|
65K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep secures second US patent grant for eftilagimod alpha
|
|
weaponhead
|
29 |
18K |
0 |
12/03/21 |
12/03/21 |
ASX - By Stock
|
29
|
18K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Overall Survival data from ph IIb AIPAC breast cancer trial
|
|
weaponhead
|
248 |
115K |
8 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
248
|
115K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Pause in Trading
|
|
weaponhead
|
36 |
12K |
2 |
17/11/20 |
17/11/20 |
ASX - By Stock
|
36
|
12K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Change of Director's Interest Notice - Grant Chamberlain
|
|
weaponhead
|
11 |
4.0K |
2 |
08/11/20 |
08/11/20 |
ASX - By Stock
|
11
|
4.0K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep's Partner, EOC completes recruitment of Phase 1
|
|
weaponhead
|
19 |
9.8K |
12 |
20/03/20 |
20/03/20 |
ASX - By Stock
|
19
|
9.8K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Change of Director's Interest Notice - Mr Chamberlain
|
|
weaponhead
|
45 |
22K |
10 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
45
|
22K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Clinical Update & Results Global Webcast Slides
|
|
weaponhead
|
88 |
1.5M |
27 |
25/02/20 |
25/02/20 |
ASX - By Stock
|
88
|
1.5M
|
27
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Clinical Update & Results Global Webcast Slides
|
|
weaponhead
|
88 |
1.5M |
18 |
25/02/20 |
25/02/20 |
ASX - By Stock
|
88
|
1.5M
|
18
|
|
ASX - By Stock
|
IMM |
Re:
IMM Coronavirus
|
|
weaponhead
|
21 |
32K |
2 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
21
|
32K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Corporate Presentation
|
|
weaponhead
|
128 |
77K |
4 |
20/01/20 |
20/01/20 |
ASX - By Stock
|
128
|
77K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Investor Update
|
|
weaponhead
|
109 |
70K |
5 |
17/12/19 |
17/12/19 |
ASX - By Stock
|
109
|
70K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Appendix 4C - quarterly
|
|
weaponhead
|
44 |
23K |
7 |
25/10/19 |
25/10/19 |
ASX - By Stock
|
44
|
23K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
weaponhead
|
308 |
136K |
16 |
09/07/19 |
09/07/19 |
ASX - By Stock
|
308
|
136K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
weaponhead
|
308 |
136K |
1 |
07/07/19 |
07/07/19 |
ASX - By Stock
|
308
|
136K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
weaponhead
|
308 |
136K |
2 |
07/07/19 |
07/07/19 |
ASX - By Stock
|
308
|
136K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
weaponhead
|
308 |
136K |
2 |
06/07/19 |
06/07/19 |
ASX - By Stock
|
308
|
136K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
weaponhead
|
152 |
54K |
3 |
26/04/19 |
26/04/19 |
ASX - By Stock
|
152
|
54K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
weaponhead
|
152 |
54K |
7 |
26/04/19 |
26/04/19 |
ASX - By Stock
|
152
|
54K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Appendix 4C - quarterly
|
|
weaponhead
|
5 |
3.4K |
7 |
26/04/19 |
26/04/19 |
ASX - By Stock
|
5
|
3.4K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
ASX vs NASDAQ
|
|
weaponhead
|
167 |
99K |
3 |
23/03/19 |
23/03/19 |
ASX - By Stock
|
167
|
99K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
ASX vs NASDAQ
|
|
weaponhead
|
167 |
99K |
1 |
19/03/19 |
19/03/19 |
ASX - By Stock
|
167
|
99K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Half Year Accounts
|
|
weaponhead
|
1 |
2.3K |
15 |
27/02/19 |
27/02/19 |
ASX - By Stock
|
1
|
2.3K
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Immunotherapy Market value
|
|
weaponhead
|
39 |
20K |
4 |
09/02/19 |
09/02/19 |
ASX - By Stock
|
39
|
20K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep enters into collaboration with CYTLIMIC
|
|
weaponhead
|
20 |
11K |
8 |
22/01/19 |
22/01/19 |
ASX - By Stock
|
20
|
11K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Immutep
|
|
weaponhead
|
51 |
25K |
6 |
08/01/19 |
08/01/19 |
ASX - By Stock
|
51
|
25K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Immutep
|
|
weaponhead
|
51 |
25K |
16 |
08/01/19 |
08/01/19 |
ASX - By Stock
|
51
|
25K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Patent question
|
|
weaponhead
|
19 |
8.6K |
1 |
18/11/18 |
18/11/18 |
ASX - By Stock
|
19
|
8.6K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Patent question
|
|
weaponhead
|
19 |
8.6K |
0 |
18/11/18 |
18/11/18 |
ASX - By Stock
|
19
|
8.6K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep presentation for BioCentury NewsMakers conference
|
|
weaponhead
|
12 |
11K |
3 |
08/09/18 |
08/09/18 |
ASX - By Stock
|
12
|
11K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
weaponhead
|
147 |
53K |
10 |
03/08/18 |
03/08/18 |
ASX - By Stock
|
147
|
53K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Goetzpartners
|
|
weaponhead
|
18 |
10K |
9 |
03/08/18 |
03/08/18 |
ASX - By Stock
|
18
|
10K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
A question of Opdivo...
|
|
weaponhead
|
4 |
3.6K |
0 |
01/08/18 |
01/08/18 |
ASX - By Stock
|
4
|
3.6K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Exceptional Management....
|
|
weaponhead
|
13 |
5.5K |
0 |
28/07/18 |
28/07/18 |
ASX - By Stock
|
13
|
5.5K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Andy or Red
|
|
weaponhead
|
10 |
5.5K |
3 |
03/06/18 |
03/06/18 |
ASX - By Stock
|
10
|
5.5K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
AGM
|
|
weaponhead
|
316 |
97K |
29 |
26/05/18 |
26/05/18 |
ASX - By Stock
|
316
|
97K
|
29
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Webcast to discuss interim results from TACTI-mel
|
|
weaponhead
|
9 |
6.1K |
1 |
17/05/18 |
17/05/18 |
ASX - By Stock
|
9
|
6.1K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
IMM recommendation
|
|
weaponhead
|
39 |
25K |
1 |
16/05/18 |
16/05/18 |
ASX - By Stock
|
39
|
25K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
IMM recommendation
|
|
weaponhead
|
39 |
25K |
2 |
16/05/18 |
16/05/18 |
ASX - By Stock
|
39
|
25K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Is the train leaving the station?
|
|
weaponhead
|
350 |
97K |
7 |
15/05/18 |
15/05/18 |
ASX - By Stock
|
350
|
97K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
O/N Nasdaq
|
|
weaponhead
|
629 |
256K |
4 |
15/05/18 |
15/05/18 |
ASX - By Stock
|
629
|
256K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
This week/next week and ASCO2018
|
|
weaponhead
|
3 |
2.2K |
12 |
13/05/18 |
13/05/18 |
ASX - By Stock
|
3
|
2.2K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep enters into collaboration with MSD
|
|
weaponhead
|
125 |
68K |
2 |
19/03/18 |
19/03/18 |
ASX - By Stock
|
125
|
68K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep enters into collaboration with MSD
|
|
weaponhead
|
125 |
68K |
1 |
13/03/18 |
13/03/18 |
ASX - By Stock
|
125
|
68K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep enters into collaboration with MSD
|
|
weaponhead
|
125 |
68K |
4 |
12/03/18 |
12/03/18 |
ASX - By Stock
|
125
|
68K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Honestly
|
|
weaponhead
|
16 |
7.7K |
0 |
24/02/18 |
24/02/18 |
ASX - By Stock
|
16
|
7.7K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Bristol-Myers Squibb says it will pay a record $1.85 billion to Nektar
|
|
weaponhead
|
41 |
15K |
2 |
22/02/18 |
22/02/18 |
ASX - By Stock
|
41
|
15K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Asia presentation
|
|
weaponhead
|
44 |
16K |
7 |
19/02/18 |
19/02/18 |
ASX - By Stock
|
44
|
16K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Answers from Wayne
|
|
weaponhead
|
56 |
22K |
1 |
02/02/18 |
02/02/18 |
ASX - By Stock
|
56
|
22K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives USD1M milestone payment from EOC
|
|
weaponhead
|
24 |
10K |
3 |
02/02/18 |
02/02/18 |
ASX - By Stock
|
24
|
10K
|
3
|
|